Not currently recruiting at UCSD
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Summary
- Eligibility
- for people ages 12 years and up (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Celgene
- Links
- Related Info
- ID
- NCT02531126
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated